tiprankstipranks
Trending News
More News >
Tempest Therapeutics (TPST)
NASDAQ:TPST
US Market

Tempest Therapeutics (TPST) Income Statement

Compare
1,262 Followers

Tempest Therapeutics Income Statement

Last quarter (Q3 2025), Tempest Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Tempest Therapeutics's net income was $-3.51M. See Tempest Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -389.00K$ 0.00$ 0.00$ 0.00$ -815.00K
Operating Expenses
$ 41.64M$ 29.16M$ 34.64M$ 26.99M$ 18.48M
Depreciation and Amortization
$ 389.00K$ 381.00K$ 638.00K$ 374.00K$ 815.00K
EBITDA
$ -40.14M$ -27.66M$ -33.45M$ -26.65M$ -18.39M
Operating Income
$ -42.03M$ -29.16M$ -34.64M$ -26.99M$ -19.30M
Other Income/Expenses
$ 183.00K$ -334.00K$ -1.07M$ -1.32M$ 90.00K
Pretax Income
$ -41.84M$ -29.49M$ -35.71M$ -28.30M$ -19.21M
Net Income
$ -41.84M$ -29.49M$ -35.71M$ -28.30M$ -19.12M
Per Share Metrics
Basic EPS
$ -1.50$ -1.91$ -3.18$ -7.80$ -612.56
Diluted EPS
$ -1.50$ -1.91$ -3.18$ -7.80$ -612.56
Weighted Average Shares Outstanding
27.90M 15.42M 888.00K 291.00K 31.21K
Weighted Average Shares Outstanding (Diluted)
27.90M 15.42M 888.38K 291.56K 31.21K
Currency in USD

Tempest Therapeutics Earnings and Revenue History